Incidental detection of maternal malignancy in non-reportable results from non-invasive prenatal testing: experience in Hong Kong and literature review.
Oct 2026· Hong Kong medical journal = Xianggang yi xue za zhi· 0 citations
Medicine
TL;DR
Although rare, occult maternal malignancy represents 3.82% of non-reportable NIPT results and should be included in pre-test counselling and may warrant early oncological evaluation.
Abstract
INTRODUCTION
Non-invasive prenatal testing (NIPT) for fetal aneuploidy occasionally yields non-reportable results due to persistent 'noisy' signals, which may indicate occult maternal malignancy. This study investigated the clinical and genetic implications of non-reportable NIPT results, focusing on multiple chromosomal aberrations associated with maternal malignancy, with the goal of developing standardised management protocols for pregnant women with such suspicious NIPT results.
Methods
From 2020 to 2023, women with persistent non-reportable NIPT results were identified and followed up in Hong Kong. Cancer cases were analysed for clinical history and chromosomal patterns. Incidental cancer detection rates were calculated and compared with literature reports. Tag Z-score chromosomal abnormalities were compared between cancer and non-cancer groups; the corresponding sensitivity and specificity were calculated.
Results
Among 84 446 NIPT tests, 151 (0.18%) showed persistent noisy signals. Of 131 patients with follow-up data, five (3.82%) were diagnosed with maternal malignancy; the overall incidental detection rate was 0.006% (5 of 84 446). Although three women delivered healthy babies, most presented with late-stage cancer confirmed by imaging and biopsy. All five cases exhibited ≥3 chromosomal aberrations on repeat NIPT; chromosome 18 was consistently involved. Univariate analysis revealed significant differences in Tag Z-score frequencies for chromosomes 18 (P=0.026) and 21 (P=0.029) between cancer and non-cancer groups. A clinical flowchart was developed to guide management of patients with multiple aberrations.
Conclusion
Although rare, occult maternal malignancy represents 3.82% of non-reportable NIPT results. This risk should be included in pre-test counselling and may warrant early oncological evaluation. Whole-body magnetic resonance imaging should be considered to facilitate cancer diagnosis.
Objective To investigate the prenatal diagnostic outcomes of pregnant women with high-risk non-invasive prenatal testing (NIPT) results and to explore factors influencing the positive predictive value (PPV) of NIPT. Methods Clinical data from 1,326 pregnant women with high-risk NIPT results who underwent invasive prena...
Run-Xuan Du, Bin-Xiu Zhao, Xue-Dong Shi et al.· Frontiers in Genetics· 0 citations
Background Noninvasive prenatal testing (NIPT) has been widely adopted for screening common fetal chromosomal aneuploidies, yet discordance between NIPT results and true fetal karyotypes remains a critical challenge limiting its clinical utility. Methods We retrospectively analyzed 97, 743 pregnant women who underwent...
Hai-Mei Qi, Hai-Jun Chen, Xian-Ping Yuan et al.· Frontiers in Endocrinology· 0 citations
Background Deletions and duplications within the 15q11q13 chromosomal region are associated with Prader-Willi syndrome, Angelman syndrome, and 15q11q13 duplication syndrome. However, prenatal ultrasound findings were unremarkable in the majority of affected fetuses. The aim of this study was to evaluate the efficacy of...
Di-Yu Chen, Liang Hu, Hong-Yan Niu et al.· Frontiers in Genetics· 0 citations
Most evidence on chromosomal microarray analysis (CMA) and exome sequencing (ES) in prenatal diagnosis comes from high-volume centres. We evaluated the incremental diagnostic contribution of additional testing modalities, non-invasive prenatal testing (NIPT) confirmation rates and pregnancy outcomes at a regional centr...
To investigate copy number variant (CNV) results in 472 fetuses with non-structural ultrasound abnormalities among pregnant women under 35 years, and analyze the association between adverse obstetric history and pathogenic/likely pathogenic (P/LP) CNVs and variants of uncertain significance (VUS).
A total of...
Li-Fang Lin, He-Ming Wu, Zhi-Yuan Zheng et al.· Frontiers in Genetics· 0 citations
Non-invasive prenatal testing (NIPT) is a method that uses cell-free fetal DNA in maternal blood sample to detect common fetal chromosomal aneuploidies. It has been recognized as the most clinically robust screening method and widely used worldwide. Although clinical validation and implementation of NIPT studies have c...
Yousef Al-Hajaya· Research Journal of Pharmacy...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.